Nils Bolstad

  • Head physician, PhD
  • +47 22 93 59 05
 

Publications 2019

Buer LCT, Moum BA, Cvancarova M, Warren DJ, Bolstad N, Medhus AW, Hoivik ML (2019)
Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort
Scand. J. Gastroenterol., 54 (1), 41-48

Goll GL, Jorgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak O, Baigh S, Blomgren IM, Brenna O, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G et al. (2019)
Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial
J. Intern. Med., 285 (6), 653-669

Smeland KB, Loge JH, Aass HCD, Aspelin T, Bersvendsen H, Bolstad N, Fagerli UM, Falk RS, Fluge O, Fossa A, Holte H, Lund MB, Murbraech K, Reinertsen KV, Stenehjem JS, Kiserud CE (2019)
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
Bone Marrow Transplant., 54 (4), 607-610

Publications 2018

Carlsen A, Omdal R, Leitao KO, Isaksen K, Hetta AK, Karlsen LN, Aabakken L, Bolstad N, Warren D, Lundin KEA, Grimstad T (2018)
Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease
Ther. Adv. Gastroenterol., 11, UNSP 1756284818759930

Glintborg B, Kringelbach T, Bolstad N, Warren DJ, Eng G, Sorensen IJ, Loft AG, Hendricks O, Hansen IMJ, Linauskas A, Nordin H, Kristensen S, Lindegaard H, Jensen DV, Goll GL, Hogdall E, Gehin J, Enevold C, Nielsen CH, Krogh NS, Johansen JS, Hetland ML (2018)
Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care
Scand. J. Rheumatol., 47 (5), 418-421

Hoivik ML, Buer LCT, Cvancarova M, Warren DJ, Bolstad N, Moum BA, Medhus AW (2018)
Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population
Scand. J. Gastroenterol., 53 (6), 692-699

Nome RV, Bjoro T, Paus E, Bjerner J, Fossa SD, Steen R, Nustad K, Bolstad N (2018)
Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors
Clin. Biochem., 52, 73-79

Thomsen M, Skovlund E, Sorbye H, Bolstad N, Nustad KJ, Glimelius B, Pfeiffer P, Kure EH, Johansen JS, Tveit KM, Christoffersen T, Guren TK (2018)
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
Br. J. Cancer, 118 (12), 1609-1616

Ueland T, Gullestad L, Kou L, Aukrust P, Anand IS, Broughton MN, McMurray JJ, van Veldhuisen DJ, Warren DJ, Bolstad N (2018)
Pro-gastrin-releasing peptide and outcome in patients with heart failure and anaemia: results from the RED-HF study
ESC Heart Fail., 5 (6), 1052-1059

Publications 2017

Bader LI, Solberg SM, Kaada SH, Bolstad N, Warren DJ, Gavasso S, Gjesdal CG, Vedeler CA (2017)
Assays for Infliximab Drug Levels and Antibodies: AMatter of Scales and Categories
Scand. J. Immunol., 86 (3), 165-170

Hov KR, Bolstad N, Idland AV, Zetterberg H, Blennow K, Chaudhry FA, Frihagen F, Raeder J, Wyller TB, Watne LO (2017)
Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium
Dement. Geriatr. Cogn. Disord. Extra, 7 (3), 374-385

Jorgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mork C, Jahnsen J, Kvien TK, NOR-SWITCH Study Grp (2017)
Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
Lancet, 389 (10086), 2304-2316

Paur I, Lilleby W, Bohn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjoro T, Laake P, Tasken KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fossa SD, Smeland SS, Karlsen AS, Blomhoff R (2017)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin. Nutr., 36 (3), 672-679

Publications 2016

Halvorsen AR, Bjaanaes M, LeBlanc M, Holm AM, Bolstad N, Rubio L, Penalver JC, Cervera J, Mojarrieta JC, Lopez-Guerrero JA, Brustugun OT, Helland A (2016)
A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer
Oncotarget, 7 (24), 37250-37259

Publications 2015

Benterud T, Pankratov L, Solberg R, Bolstad N, Skinningsrud A, Baumbusch L, Sandvik L, Saugstad OD (2015)
Perinatal Asphyxia May Influence the Level of Beta-Amyloid (1-42) in Cerebrospinal Fluid: An Experimental Study on Newborn Pigs
PLoS One, 10 (10), e0140966

Gislefoss RE, Langseth H, Bolstad N, Nustad K, Morkrid L (2015)
HE4 as an Early Detection Biomarker of Epithelial Ovarian Cancer Investigations in Prediagnostic Specimens From the Janus Serumbank
Int. J. Gynecol. Cancer, 25 (9), 1608-1615

Publications 2013

Bolstad N, Warren DJ, Nustad K (2013)
Heterophilic antibody interference in immunometric assays
Best Pract Res Clin Endocrinol Metab, 27 (5), 647-61
DOI 10.1016/j.beem.2013.05.011, PubMed 24094636

Publications 2012

Bjerner J, Bolstad N, Piehler A (2012)
Belief is only half the truth--or why screening for heterophilic antibody interference in certain assays makes double sense
Ann Clin Biochem, 49 (Pt 4), 381-6
DOI 10.1258/acb.2012.011228, PubMed 22740684

Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
A man with abdominal pain: enough evidence for surgery?
Clin Chem, 58 (8), 1187-90
DOI 10.1373/clinchem.2011.167015, PubMed 22843812

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K (2012)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera (vol 49, pg 2001, 2011)
Clin. Chem. Lab. Med., 50 (2), 409

Sachse D, Bolstad N, Jonsson M, Sæves I, Johansson CB, Delezuch W, Hagve M, Hardang IM, Isaksson HS, Ivarsson A, Lehto L, Keikkala E, Mattsson N, Ranta JK, Stavelin A, Sudmann AA, Varsi K (2012)
The Accu-Chek Mobile blood glucose monitoring system used under controlled conditions meets ISO 15197 standards in the hands of diabetes patients
Scand J Clin Lab Invest, 72 (5), 374-9
DOI 10.3109/00365513.2012.677544, PubMed 22900743

Publications 2011

Bolstad N, Warren DJ, Bjerner J, Kravdal G, Schwettmann L, Olsen KH, Rustad P, Nustad K (2011)
Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
Clin Chem Lab Med, 49 (12), 2001-6
DOI 10.1515/CCLM.2011.702, PubMed 21899496

Bolstad N, Øijordsbakken M, Nustad K, Bjerner J (2011)
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
Tumour Biol, 33 (1), 141-8
DOI 10.1007/s13277-011-0256-4, PubMed 22105734

Publications 2008

Krokeide SZ, Bolstad N, Laerdahl JK, Bjørås M, Luna L (2008)
Expression and purification of NEIL3, a human DNA glycosylase homolog
Protein Expr Purif, 65 (2), 160-4
DOI 10.1016/j.pep.2008.11.014, PubMed 19121397

Publications 2007

Hildrestrand GA, Diep DB, Kunke D, Bolstad N, Bjørås M, Krauss S, Luna L (2007)
The capacity to remove 8-oxoG is enhanced in newborn neural stem/progenitor cells and decreases in juvenile mice and upon cell differentiation
DNA Repair (Amst), 6 (6), 723-32
DOI 10.1016/j.dnarep.2006.12.008, PubMed 17236821

Page visits: 2153